Cart
sales@molnova.com
Libenzapril
CAS No. 109214-55-3
Libenzapril( —— )
Catalog No. M34314 CAS No. 109214-55-3
Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 592 | In Stock |
|
| 10MG | 843 | In Stock |
|
| 25MG | 1264 | In Stock |
|
| 50MG | 1655 | In Stock |
|
| 100MG | 2260 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLibenzapril
-
NoteResearch use only, not for human use.
-
Brief DescriptionLibenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
-
DescriptionLibenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetACE
-
RecptorAngiotensin-converting Enzyme (ACE)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number109214-55-3
-
Formula Weight363.41
-
Molecular FormulaC18H25N3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(O)=O)N1C=2C(CC[C@H](N[C@@H](CCCCN)C(O)=O)C1=O)=CC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Omapatrilat
A potent, dual inhibitor of the metalloproteases ACE and NEP with Ki of 0.64 nM and 0.45 nM, respectively.
-
Rentiapril racemate
Rentiapril racemate (SA-446 racemate) is the racemic form of Rentiapril, exhibiting anti-inflammatory properties and potential applications in glaucoma research.
-
MLN-4760
MLN-4760 (MLN4760) is a potent, selective inhibitor of angiotensin-converting enzyme (ACE)-related carboxypeptidase ACE2 with IC50 of 0.44 nM (hACE2).
